Olivier BORTOLOTTI

Dr. Olivier BORTOLOTTI

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2025 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
JLJulien De Lima
Julien De Lima
MBMarie-Astrid Boutet
Marie-Astrid Boutet
OBOlivier BORTOLOTTI
Olivier BORTOLOTTI
LCLaure-Agnès Chépeaux
Laure-Agnès Chépeaux
YGYaël Glasson
Yaël Glasson
FBFrederic Blanchard
Frederic Blanchard
Despite advances in rheumatoid arthritis (RA) treatment, a significant proportion of patients fail to achieve adequate remission. The dynamic cellular and architectural changes within the synovium that underpin therapeutic success remain poorly understood. This study aimed to unravel the synovial landscape during effective RA treatment, identifying key cellular networks and molecular pathways associated with remission. We performed high-dimensional imaging mass cytometry on synovial tissues from healthy controls, patients with osteoarthritis, and patients with early RA longitudinally before and after 6 months of conventional synthetic disease-modifying antirheumatic drugs (csDMARD) therapy. Findings were validated using whole-tissue RNA-sequencing and immunofluorescence in larger patient cohorts, and integrated with ligand-receptor analyses from public single-cell RNA-seq datasets and in vitro functional coculture assays. Our deep spatial profiling pinpointed a critical LYVE1+CD206+tissue-resident macrophage network, localised within perivascular niches alongside fibroblasts and vascular cells. This homeostatic network was disrupted in active RA but restored in patients responding well to csDMARDs. This restoration correlated with the re-establishment of specific cell-cell interactions and was governed by distinct molecular pathways, including chemokines, annexins, and TAM (TYRO3, AXL, MERTK) receptors. Functionally, LYVE1+ macrophages demonstrated a regulatory, anti-inflammatory phenotype in vitro, contrasting with proinflammatory myeloid cells. This study provides an unprecedented spatial and dynamic blueprint of the RA synovium's response to therapy. We identify the LYVE1+ macrophage network as a pivotal component of synovial homeostasis and its restoration as a hallmark of clinical remission. These findings unveil novel cellular and molecular targets, paving the way for more active therapeutic strategies.

25 March 2022 in Cells
Verified
Journal Article
Open access
PDF file
JLJulien Louradour
Julien Louradour
OBOlivier BORTOLOTTI
Olivier BORTOLOTTI
ETEleonora Torre
Eleonora Torre
IBIsabelle Bidaud
Isabelle Bidaud
NLNed Lamb
Ned Lamb
PMPietro Mesirca
Pietro Mesirca
Background: Sinoatrial node cells (SANC) automaticity is generated by functional association between the activity of plasmalemmal ion channels and local diastolic intracellular Ca2+ release (LCR) from ryanodine receptors. Strikingly, most isolated SANC exhibit a “dormant” state, whereas only a fraction shows regular firing as observed in intact SAN. Recent studies showed that β-adrenergic stimulation can initiate spontaneous firing in dormant SANC, though this mechanism is not entirely understood. Methods: To investigate the role of L-type Cav1.3 Ca2+ channels in the adrenergic regulation of automaticity in dormant SANC, we used a knock-in mouse strain in which the sensitivity of L-type Cav1.2 α1 subunits to dihydropyridines (DHPs) was inactivated (Cav1.2DHP−/−), enabling the selective pharmacological inhibition of Cav1.3 by DHPs. Results: In dormant SANC, β-adrenergic stimulation with isoproterenol (ISO) induced spontaneous action potentials (AP) and Ca2+ transients, which were completely arrested with concomitant perfusion of the DHP nifedipine. In spontaneously firing SANC at baseline, Cav1.3 inhibition completely reversed the effect of β-adrenergic stimulation on AP and the frequency of Ca2+ transients. Confocal calcium imaging of SANC showed that the β-adrenergic-induced synchronization of LCRs is regulated by the activity of Cav1.3 channels. Conclusions: Our study shows a novel role of Cav1.3 channels in initiating and maintaining automaticity in dormant SANC upon β-adrenergic stimulation.

21 September 2025 in Arthritis & Rheumatology
Verified
Journal Article
Open access
DLDamien Laouteouet
Damien Laouteouet
OBOlivier BORTOLOTTI
Olivier BORTOLOTTI
LMLéa Marineche
Léa Marineche
NHNicole Hannemann
Nicole Hannemann
MCManon Chambon
Manon Chambon
Gabriel CourtiesGabriel Courties
Gabriel Courties
Objective: Osteoarthritis (OA) is a debilitating joint disease that is characterized by cartilage degradation, synovial inflammation, and pain. Macrophages have been implicated in OA pathology, but the origins and functions of diverse macrophage subsets seeding the synovial joint tissue remain incompletely understood. This study investigates macrophage heterogeneity, ontogeny, fate, and communication with stromal niche cells in OA. Methods: Single‐cell RNA sequencing was employed on synovial cells isolated from mice with collagenase‐induced OA (CiOA) and CD14 + macrophages from four patients with OA. We combined flow cytometry, genetic fate mapping, and imaging mass cytometry to profile synovial macrophage subsets. Cell–cell communication analyses were performed to investigate cellular network interactions. Results: Three macrophage subsets with distinct gene signatures and origins were identified in CiOA, including contributions to synovial inflammation and tissue remodeling. Fate mapping via CCR2‐creER and CX3CR1‐creER mice revealed the expansion of monocyte‐derived TIM4 − MHCII low/high macrophages. Monocyte‐independent TIM4 + CX3CR1 + macrophages operated a synovial niche shift, migrating near vascularized structures in the synovial subintima. Notably, the Oncostatin M (OSM)/OSM receptor (OSMR) signaling network emerged as a critical pathway linking recruited CCR2‐derived macrophages to fibroblast activation. In individuals with OA, single‐cell transcriptomics identified a conserved MERTK low CD48 high CCR2 + macrophage subpopulation as a key source of OSM. Conclusion: Our study provides insights into macrophage subsets and their interplay with the joint microenvironment, bridging the gap between their origins, transcriptomic profiles, and roles in OA. Specifically, the OSM/OSMR axis represents a pivotal mechanism in recruited macrophage‐fibroblast crosstalk, offering potential targets for novel biomarkers and therapies to manage OA‐related synovitis. image

22 October 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
JLJulien De Lima
Julien De Lima
MBMarie-Astrid Boutet
Marie-Astrid Boutet
OBOlivier BORTOLOTTI
Olivier BORTOLOTTI
LCLaure-Agnès Chépeaux
Laure-Agnès Chépeaux
YGYaël Glasson
Yaël Glasson
FBFrederic Blanchard
Frederic Blanchard
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease affecting peripheral joints and for which approximately 40% of the patients respond insufficiently to the available synthetic or biologic disease modifying anti-rheumatic drugs (DMARDs). The infiltration of the synovial membrane by lymphocytes and monocytes profoundly alters its homeostatic functions, leading to chronic joint inflammation and bone destruction. A better understanding of how DMARDs impact the complex synovial cell social network in relationship to response/ non-response remains an unmet need to design more targeted and active therapeutic strategies. Here, we used imaging mass cytometry (IMC) to comparatively profile more than 115,000 cells in the synovial tissue of healthy, low inflammatory osteoarthritis and matched active early treatment-naïve RA patients at baseline and at 6 months after starting DMARDs treatment. We notably highlighted that tissue resident macrophages (LYVE1 + CD206 + ) in perivascular synovial niches encompassing specific subsets of vascular cells, fibroblasts and immune cells vanished in active RA but were recovered in response to DMARDs treatment. Combined ligand-receptor analysis of single-cell RNA sequencing datasets identified that IL10, C-type lectin or TAM (TYRO3, AXL and MERTK) receptors were particularly involved in the restoration of these spatial cell interactions in the context of clinical remission. In addition to providing an unprecedented synovial spatial mapping, our work uncovered novel potential cellular and molecular targets for the development of therapies for RA. One Sentence Summary: Single-cell spatial profiling of rheumatoid arthritis synovium identifies specific cell states linked to treatment response

1 December 2021 in Revue du Rhumatisme
Verified
Journal Article
Closed access
NHN. Hannemann
N. Hannemann
DLD. Laouteouet
D. Laouteouet
OBOlivier BORTOLOTTI
Olivier BORTOLOTTI
IDI. Duroux-Richard
I. Duroux-Richard
FAF. Apparailly
F. Apparailly
GCG. Courties
G. Courties

30 May 2025 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
OBOlivier BORTOLOTTI
Olivier BORTOLOTTI
LMLea Marineche
Lea Marineche
BABienfait Abasi Ali
Bienfait Abasi Ali
CBChristelle Bertrand-Gaday
Christelle Bertrand-Gaday
DSDany Severac
Dany Severac
GCGabriel Courties
Gabriel Courties